ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 670

$830K Total Retail Price of All Prescriptions

Rank: 63 out of 670

578 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 9,491 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 486 402 1 4
OMEPRAZOLE 442 322 2 5
LEVOTHYROXINE SODIUM 402 293 3 2
HYDROCHLOROTHIAZIDE 370 335 4 10
ENALAPRIL MALEATE 316 244 5 49
METFORMIN HCL ER 292 252 6 63
FUROSEMIDE 241 178 7 6
AMLODIPINE BESYLATE 209 171 8 7
NEXIUM 207 163 9 14
ATORVASTATIN CALCIUM 192 175 10 15
SERTRALINE HCL 192 119 10 22
METOPROLOL SUCCINATE 184 130 12 12
METOPROLOL TARTRATE 184 151 12 9
ATENOLOL 179 125 14 17
LISINOPRIL 172 147 15 3
POTASSIUM CHLORIDE 160 129 16 16
TRAMADOL HCL 156 131 17 21
AZITHROMYCIN 148 109 18 35
GLIMEPIRIDE 146 86 19 32
METFORMIN HCL 136 77 20 8
IBUPROFEN 132 86 21 50
PRAVASTATIN SODIUM 120 88 22 19
GABAPENTIN 119 66 23 11
HYDROCODONE-ACETAMINOPHEN 118 97 S3 24 1
PANTOPRAZOLE SODIUM 116 82 25 41
FLUOXETINE HCL 113 75 26 55
SYNTHROID 112 92 27 47
MECLIZINE HCL 109 96 28 114
CLOPIDOGREL 106 84 29 24
CITALOPRAM HBR 106 95 29 20
LOSARTAN POTASSIUM 105 79 31 26
MIRTAZAPINE 99 68 32 59
MELOXICAM 96 77 33 33
TAMSULOSIN HCL 92 88 34 30
CRESTOR 90 77 35 18
WARFARIN SODIUM 89 82 36 13
BUSPIRONE HCL 84 57 37 124
LANSOPRAZOLE 80 67 38 86
AMLODIPINE BESYLATE-BENAZEPRIL 74 74 39 74
AMITRIPTYLINE HCL 73 58 R 40 68
TRAZODONE HCL 73 40 40 39
LOVASTATIN 72 55 42 44
DONEPEZIL HCL 71 68 43 31
FENOFIBRATE 69 41 44 64
LEVOFLOXACIN 68 58 45 88
PLAVIX 68 58 45 34
NAMENDA 65 62 47 54
NITROSTAT 64 57 48 155
BENAZEPRIL HCL 63 46 49 90
DIGOXIN 61 53 50 46
SINGULAIR 61 48 50 56
HYDROXYZINE PAMOATE 61 38 R 50 169
ISOSORBIDE MONONITRATE ER 61 48 50 45
PROAIR HFA 59 35 54 28
CARBIDOPA-LEVODOPA 58 51 55 101
FLUTICASONE PROPIONATE 53 44 56 37
ACYCLOVIR 51 29 57 365
BYSTOLIC 51 51 57 165
RAMIPRIL 50 28 59 115
DIOVAN 50 48 59 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.